These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5408200)

  • 21. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 22. [Our experience with lumbar gangliectomy in treatment of chronic peripheral obliterating arteriopathy of the lower extremities].
    Longhino C; Postiglione G; Portis PA
    Osp Ital Chir; 1968; 19(4):375-94. PubMed ID: 5718566
    [No Abstract]   [Full Text] [Related]  

  • 23. [Behavior and significance of beta-thromboglobulin in chronic obliterating arteriopathy of the lower limbs. Preliminary research].
    Binaghi F; Valle E; Manconi E; Pitzus F
    Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6085827
    [No Abstract]   [Full Text] [Related]  

  • 24. [An assessment of the efficacy of intravenous monotherapy with the preparation solcoseryl in patients with arteriosclerosis obliterans of the vessels of the lower extremities].
    Luk'ianov IuV; Shlomin VV; Sokurenko GIu; Didenko IuP; Orlov NN; Kondrat'ev VM; Batalin IV
    Vestn Khir Im I I Grek; 2000; 159(3):81-4. PubMed ID: 10983350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin].
    Gau HP
    Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754
    [No Abstract]   [Full Text] [Related]  

  • 26. [Considerations on the activation of the regional fibrinolytic system of the extremities in subjects with obliterating arteriopathy with a malignant course].
    Brunetti S; Tesi M; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):443-54. PubMed ID: 5603689
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of the sulfonic ester of adrenochrome semicarbazone in the therapy of phlebopathies and obliterating arteriosclerotic arteriopathies of the lower extremities].
    Seghezzi R; Pedroni G; Ercoli A
    Chir Ital; 1967; 19():Suppl 2:349+. PubMed ID: 5190607
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with treatment of obliterating atherosclerosis of the lower extremities with vitamin A and E under ambulatory conditions].
    Nechaev EB
    Vrach Delo; 1966 May; 5():128-9. PubMed ID: 5995479
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of patients with obliterating diseases of the arteries of the lower extremities with regional vacuum electrophoresis].
    Buiavykh AG
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):126-7. PubMed ID: 6719709
    [No Abstract]   [Full Text] [Related]  

  • 30. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
    Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of bencyclane on blood perfusion of the limbs].
    Solti F
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1358+. PubMed ID: 5536637
    [No Abstract]   [Full Text] [Related]  

  • 32. [Central and peripheral circulation in arteriosclerosis obliterans of the lower extremities before and after surgical treatment].
    Barinov VS; Shcherbina NG
    Vestn Khir Im I I Grek; 1982 Jun; 128(6):58-62. PubMed ID: 7123769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 34. [The volume rate of blood flow in the arteries of the lower extremities in occlusive arterial diseases].
    Alekseev PP; Sadekova AK
    Vestn Khir Im I I Grek; 1967 Nov; 98(11):21-5. PubMed ID: 5607644
    [No Abstract]   [Full Text] [Related]  

  • 35. [Production of lactic acid and acid-base equilibrium in the triangular effort test 10 watts-minute in obliterating arteriopathy of the lower extremities].
    Cherchi A; Raffo M; Maxia L; Verzetti G; Bina M; Fonzo R
    Boll Soc Ital Cardiol; 1969; 14(3):386-99. PubMed ID: 5408187
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on peripheral arterial blood circulation disorders. XV. On the problems of conservative therapy of obliterating peripheral blood circulation disorders demonstrated on tincture and extract from Ginkgo biloba L].
    Mussgnug G; Alemany J
    Arzneimittelforschung; 1968 May; 18(5):543-50. PubMed ID: 5755881
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostacyclin in the therapy of peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P
    Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and hemodynamic aspects induced by eledoisin. Plethysmographic study of variations of flow in some forms of obliterating arterial disease of the legs, during intra-arterial infusion of eledoisin].
    Chiampo L; La Greca G; Ferrari S; Novarini A
    Minerva Cardioangiol; 1965 Jul; 13(7):375-82. PubMed ID: 5838537
    [No Abstract]   [Full Text] [Related]  

  • 39. [Arterial auscultation and phono-arteriography as methods of investigation of peripheral obliterating arteriopathy].
    Longo T; Meciani L; Santa A; Tealdi D
    Minerva Med; 1967 Nov; 58(91):3901-9. PubMed ID: 6083284
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of regional artificial circulation in the treatment of obliterating thrombosis of the lower limbs].
    Dutkevich IG; Farshatov MN; Glebov IuI; Dekster BG
    Vestn Khir Im I I Grek; 1966 Jun; 96(6):122-6. PubMed ID: 6000568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.